Compare EVT & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVT | ATRC |
|---|---|---|
| Founded | 2003 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | EVT | ATRC |
|---|---|---|
| Price | $24.32 | $35.12 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $52.00 |
| AVG Volume (30 Days) | 115.5K | ★ 523.8K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 8.32% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 6.63 | N/A |
| Revenue | $69,404,302.00 | ★ $518,304,999.00 |
| Revenue This Year | N/A | $16.90 |
| Revenue Next Year | N/A | $12.29 |
| P/E Ratio | $3.55 | ★ N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $19.20 | $28.29 |
| 52 Week High | $25.83 | $43.11 |
| Indicator | EVT | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 52.47 | 50.72 |
| Support Level | $23.00 | $35.51 |
| Resistance Level | $24.55 | $38.90 |
| Average True Range (ATR) | 0.39 | 1.72 |
| MACD | 0.06 | 0.37 |
| Stochastic Oscillator | 69.55 | 50.26 |
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.